Core Scientific, Inc./tx Quarterly Liabilities and Equity in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Core Scientific, Inc./tx quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q2 2024.
  • Core Scientific, Inc./tx Liabilities and Equity for the quarter ending June 30, 2024 was $761M, a 1.41% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $761M +$10.6M +1.41% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $814M +$53.9M +7.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $712M -$95.5M -11.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $705M -$699M -49.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $751M -$1.09B -59.3% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $760M -$1.94B -71.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $808M -$1.63B -66.9% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.4B +$1.06B +305% Sep 30, 2022 10-Q 2022-11-22
Q2 2022 $1.85B +$1.5B +431% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $2.7B +$2.36B +678% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $2.44B +$2.44B Dec 31, 2021 10-K 2023-04-04
Q3 2021 $347M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $348M Jun 30, 2021 10-Q 2021-08-23
Q1 2021 $348M Mar 31, 2021 10-Q 2021-05-25
Q4 2020 $15K* Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.